Full-Time

Medical Director

Medical Strategy & Scientific Affairs

BGBx

BGBx

501-1,000 employees

Healthcare consultancy translating science into stories

Compensation Overview

$120k - $160k/yr

Remote in USA

Remote

Remote within the United States.

PharmD, PhD, MD

Category
Medical, Clinical & Veterinary (1)
Required Skills
Branding/Brand Strategy

Get referred to BGBx

See people who can refer or advise you

Requirements
  • Must have a proven record of independently executing the responsibilities and successfully demonstrating the competencies outlined for the Medical Director role and must demonstrate the ability to onboard, train, and mentor others in the Associate Medical Director, Senior Medical Writer and Medical Writer roles.
Responsibilities
  • Manages the scope of existing work and assumes primary responsibility for overseeing translation and execution of BGB standards, client expectations, and brand strategy
  • Provides strategic guidance to team/brand from kick-off through execution (reviewing for messaging and style)
  • Reviews deliverables and ensures that BGB standards, client expectations, and brand strategy are met; assumes lead role in strategy-heavy projects
  • Assumes accountability for accuracy of own work and work of reports, and works to address accuracy issues internally as they arise
  • Effectively partners with other departments (eg, art, copy, account), as appropriate, to provide out-of-the-box recommendations on how to creatively tell the brand story and reinforce the brand messages
  • Writes and annotates content as appropriate
  • Understands the brands therapeutic space and proactively provides recommendations regarding planned projects to internal and external team
  • Functions as Strategic Medical Lead during external project kickoff meetings
  • Demonstrates complete understanding of BGB process and can foresee possible challenges and suggest solutions in the project planning stage
  • Defines steps and range of time to execute content-related tasks, formalizing content development timing and benchmarks
  • May act as strategic medical brand lead
  • Interprets client expectations and incorporates into project execution plans
  • May act as Medical lead for a range of projects, calls, advisory boards, and onsite meetings
  • Comfortably, clearly, and concisely communicates with clients and KOLs and builds and maintains strong professional relationships
  • Proactively initiates discussion with client and drives internal follow-up regarding organic growth opportunities
  • Understands the role of Medical within the agency and works to set appropriate expectations and operating norms within the team
  • Shares best practices and strategic insights with internal team to maximize efficiencies and support team’s therapeutic learning/proficiency
  • Leads by example to demonstrate efficiency, teamwork, and superior scientific quality for all deliverables
  • Leads by example to utilize conflict resolution skills to address internal and external conflicts
Desired Qualifications
  • Advanced degree (PhD, PharmD, MD, or equivalent)
  • 3-4 years of experience in pharmaceutical advertising, ideally in HCP promotional workstreams
  • Experience managing and mentoring junior medical team members
  • Demonstrated success in partnering with creative, strategy, and account teams
  • Experienced in interacting with clients and KOLs

BGBx is a healthcare consultancy that helps pharmaceutical, biotech, and medical device companies turn scientific advances into practical, credible brand stories and strategies. Its services include medical communications to explain science clearly, market access planning to help products reach patients, and payer strategy to work with insurance decision-makers. The work is done by a team that combines clinical knowledge, academic insight, and industry experience, and is delivered through project-based engagements that aim for real-time, real-world impact. Unlike firms that rely on generic marketing, BGBx differentiates itself with a strong, multidisciplinary medical team and a clear focus on translating science into strategies that improve access and outcomes. The company’s goal is to help clients communicate complex science effectively while shaping reimbursement and market access to bring new therapies and devices to patients more efficiently.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

New York City, New York

Founded

2014

Get referred to BGBx

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • BGBx acquired Hayden Consulting Group in January 2026, strengthening market access demand capture.
  • BGBx's oncology access content tracks rising payer controls and stronger client urgency.
  • The company emphasizes independent, integrated execution, which appeals to pharma teams avoiding agency complexity.

What critics are saying

  • Large agency networks and consultancies can outscale BGBx's standalone model in enterprise deals.
  • BGBx's 2026 rebrand signals dependency on constant repositioning to stay relevant.
  • If pharma budgets tighten in 2027, project-based consulting revenue drops fast.

What makes BGBx unique

  • BGBx rebranded in June 2026 as a broader commercial solutions provider.
  • BGBx combines medical communications, payer strategy, market access, and execution under one roof.
  • Hayden Consulting Group and Kx Advisors deepen BGBx's strategy consulting and access expertise.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

4%

1 year growth

4%

2 year growth

5%
GlobeNewswire
Jan 7th, 2026
BGB Group acquires Hayden Consulting Group to expand market access expertise

BGB Group, a commercial solutions company for biopharmaceutical firms, has acquired Hayden Consulting Group, a market access and patient services consultancy. Financial terms were not disclosed. Hayden specialises in resolving complex payer, reimbursement and affordability challenges for global pharmaceutical brands. The acquisition combines Hayden's market access expertise with BGB's strategic advisory services, which span commercial due diligence, new product planning and go-to-market strategies. Hayden will continue to be led by co-founders Jamie Sidore and David MacDougall, becoming part of BGB's strategic advisory practice headed by Hilary Gentile. The combined entity aims to provide clients with integrated solutions across the full brand lifecycle, from early planning through commercialisation.

Citybiz
Nov 19th, 2024
BGB Group Appoints David Coman as Chief Executive Officer

BGB Group appoints David Coman as Chief Executive Officer.

MM+M
Jun 21st, 2024
BGB Group's new creative chief Chris Palmer on AI's growth potential

BGB Group recently hired Chris Palmer as its new chief creative officer, who joined from Havas Life New York.

O'Dwyer's PR
Feb 28th, 2024
On the Move: APCO's Camarco Unit Names Cohen Tech Leader

Kuzel comes to imre from BGB Group, where she was EVP data, analytics and customer experience.

Business Wire
Feb 1st, 2024
Bgb Group Announces Partnership With Scrum50 To Deliver High-Impact, Consumer-Centric Creative To Healthcare Clients

NEW YORK--(BUSINESS WIRE)--BGB Group (BGB), an award-winning healthcare commercialization and communications company headquartered in New York City with offices in Washington DC, Boston, and London, today announced a strategic partnership with Scrum50 (S50), a dynamic, agile-first creative agency based in South Norwalk, CT. This collaboration marks a transformative alliance, the next phase of BGB’s expertise enhancement aimed at remaining ahead of biopharma’s biggest challenges. The teams are set to redefine creativity and impact in the healthcare sector. S50 will continue to operate independently across all industry sectors. “We are excited to formalize our partnership with S50,” noted Greg Passaretti, Founding Partner of BGB Group. “We’ve been working together for nearly a year, and we realized that there’s much more that we can accomplish for a marketplace in need of broader creative and engagement solutions.”